Buy Jounce For A Bounce
May 18, 2018 at 12:45 PM EDT
Jounce Therapeutics announced it will present data at the ASCO conference for its candidate JTX-2011, and the Street interpreted the abstract negatively. We see this selloff as an overreaction, and one we can take a gamble on.
